AI Education Tool for Breast Cancer Patients
Part of Cancer, Skin clinical trials.
This study tests a new computer-based education module created by artificial intelligence to help breast cancer patients understand their diagnosis and treatment options. The goal is to see if this tool helps patients feel more informed and prepared for their care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with breast cancer (either stage I–III within the last 6 months, or stage IV with an upcoming treatment change)
- You have a computer or device at home with reliable internet access
- You are able to use basic computer functions like clicking, typing, and reading on a screen
- You can attend follow-up visits with your cancer doctor regularly (at least every 3 months for stage IV patients)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smartphone or computer-based educational program designed to help breast cancer patients who are about to start radiation therapy. The program uses artificial intelligence to provide personalized information and support during your treatment.
This study tests whether an AI tool can predict how well breast cancer responds to chemotherapy given before surgery. Your tumor sample from a needle biopsy will be analyzed to see if the AI's prediction matches your actual treatment outcome.
This study tests if education supported by artificial intelligence (AI) helps women recover better after breast removal surgery. If you're having a mastectomy, you may be able to join.
This study tests a new artificial intelligence software called Kenko Breast AI+ that analyzes breast MRI scans to help doctors better detect and monitor breast cancer. If you've had or are planning to have a breast MRI for cancer concerns, this trial might be right for you.
This trial tests a non-invasive, AI-based monitoring program for people with solid tumors. It aims to help track how you’re doing during or after curative-intent treatment, using information collected without extra procedures.
This trial tests a mobile app that uses artificial intelligence to help women with early-stage breast cancer manage symptoms during their first chemotherapy. The app is in Arabic and is designed to make it easier to report how you're feeling and get support.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.